Showing results (2481-2490 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|March 1, 1994
Enhanced susceptibility of Escherichia coli pretreated with RP7293 to leukocyte activity: comparison with other antimicrobial agentsP Pérez, I Herrera, M Martín, et al.Chemotherapy|January 1, 1977
Concentrations of tinidazole in body fluids and tissues in gynaecological patientsT Ripa, L Weström, P A Mårdh, et al.Chemotherapy|August 31, 2000
Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniaeB N Kim, J H Woo, Y S Kim, et al.Chemotherapy|August 31, 2000
In vitro comparative dynamics of modified-release clarithromycin and of azithromycinF Scaglione, G Demartini, S Dugnani, et al.Chemotherapy|August 31, 2000
Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: a randomized studyN Tsavaris, C Kosmas, M Vadiaka, et al.Chemotherapy|January 1, 1975
In vivo comparison of two galenic forms of ampicillin-trihydrateJ Pijck, H Soep, J L FrauxChemotherapy|January 1, 1975
Comparative pharmacokinetics and clinical experience with a new cephalosporin-derivative: cefazolinH Lode, S Gebert, A HendrischkChemotherapy|January 1, 1975
Mucolytic and antibiotic effect of a new compound in chronic bronchitisH BŭrgiChemotherapy|January 1, 1975
Results obtained with combination therapy of VM-26, natulan and prednisolone in generalized Hodgkin's diseaseS Eckhardt, E Döbrentey, I BodrogiChemotherapy|January 1, 1975
Vibramycin in paediatrics. An evaluation of the onset of action and efficacyG Herz, J GfellerPageof 308